Equillium, Inc.
EQ- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001746466
No open-market purchases or sales by Equillium, Inc. insiders were filed in the last 90 days; 60 institutions reported holding it in 13F filings for Q2 2026, worth $133.0M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Equillium, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Of which not filed for Q4 2025 | Q4 2025 | Change |
|---|---|---|---|---|
| Holders | 40 | 1 | 36 | −3 |
| Shares | 29.7M | 1.82M | 35.3M | +7.46M (+26.8%) |
| Value | $42.4M | $2.61M | $54.7M | +$14.9M (+37.4%) |
1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (8)
Institutions that held Equillium, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Janus Henderson Group PLC | 5,862,212 | $9.06M | 0.00% |
| Susquehanna International Group, LLP | 185,669 | $287.8K | 0.00% |
| Jane Street Group, LLC | 100,850 | $156.3K | 0.00% |
| Royal Bank of Canada | 79,734 | $124.0K | 0.00% |
| Two Sigma Advisers, LP | 44,100 | $68.4K | 0.00% |
| Tudor Investment Corp Et Al | 20,100 | $31.2K | 0.00% |
| Coastal Bridge Advisors, LLC | 10,500 | $16.3K | 0.00% |
| Jones Financial Companies LLLP | 250 | $388 | 0.00% |
Sold out (11)
Institutions that held Equillium, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| StemPoint Capital LP | 1,908,935 | $2.73M |
| Citadel Advisors LLC | 85,557 | $122.3K |
| Marshall Wace, LLP | 41,220 | $58.9K |
| Engineers Gate Manager LP | 39,739 | $56.8K |
| Prudential Financial Inc | 28,300 | $40.5K |
| Millennium Management LLC | 24,356 | $34.8K |
| Virtu Financial LLC | 23,779 | $34.0K |
| Two Sigma Securities, LLC | 10,544 | $15.1K |
| Simplex Trading, LLC | 1,922 | $2.00K |
| Rise Advisors, LLC | 263 | $376 |
| FMR LLC | 200 | $286 |
Not filed for Q4 2025 yet (1)
Institutions that held Equillium, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Takeda Pharmaceutical Co Ltd | 1,824,977 | $2.61M |